Literature DB >> 26327182

Hematocrit-independent recovery of immunosuppressants from DBS using heated flow-through desorption.

Christel Maria Hempen1, Emile Hermannus Maarten Koster1, Jan Albert Ooms1.   

Abstract

BACKGROUND: We applied our concept for automated flow-through desorption of DBS to investigate the effect of desorption temperature on recovery. For this purpose, a method has been developed for the determination of four immunosuppressants in DBS.
RESULTS: We compared recoveries of four immunosuppressants for measurements with and without temperature-enhanced desorption at different hematocrit (Ht) levels. Temperature-enhanced desorption increased recovery substantially for tacrolimus, sirolimus and everolimus at all Ht values and for cyclosporine At high Ht. In addition, recovery became largely independent from Ht variations. Under the optimized conditions, a brief validation using spiked blood samples showed that the method complies with acceptance criteria for quantitative bioanalysis.
CONCLUSION: This method enables a quantitative analysis of immunosuppressants in DBS independent from the Ht.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26327182     DOI: 10.4155/bio.15.97

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  5 in total

1.  Quantitation of Fentanyl Analogs in Dried Blood Spots by Flow-Through Desorption Coupled to Online Solid Phase Extraction Tandem Mass Spectrometry.

Authors:  Rebecca L Shaner; Nicholas D Schulze; Craig Seymour; Elizabeth I Hamelin; Jerry D Thomas; Rudolph C Johnson
Journal:  Anal Methods       Date:  2017-06-16       Impact factor: 2.896

2.  Quantification of saxitoxin in human blood by ELISA.

Authors:  Rebekah E Wharton; Melanie C Feyereisen; Andrea L Gonzalez; Nicole L Abbott; Elizabeth I Hamelin; Rudolph C Johnson
Journal:  Toxicon       Date:  2017-05-07       Impact factor: 3.033

3.  Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device.

Authors:  Tom C Zwart; Sumit R M Gokoel; Paul J M van der Boog; Johan W de Fijter; Dina M Kweekel; Jesse J Swen; Henk-Jan Guchelaar; Dirk Jan A R Moes
Journal:  Br J Clin Pharmacol       Date:  2018-10-15       Impact factor: 4.335

4.  Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children.

Authors:  Lisa C Martial; Rob E Aarnoutse; Michiel F Schreuder; Stefanie S Henriet; Roger J M Brüggemann; Manuela A Joore
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

5.  Quantification of 6-Mercaptopurine and Its Metabolites in Patients with Acute Lympoblastic Leukemia Using Dried Blood Spots and UPLC-MS/MS.

Authors:  Supandi Supandi; Yahdiana Harahap; Harmita Harmita; Rizka Andalusia
Journal:  Sci Pharm       Date:  2018-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.